Greater Cannabis (GCAN) Stock Price, News & Analysis

Company Overview

Greater Cannabis Acquisition Company (NASDAQ: GCAN) is a special-purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more operating businesses in the cannabis industry. Since its initial public offering, the company has focused on leveraging capital markets expertise to pursue opportunities across the rapidly evolving legal cannabis sector, with an emphasis on consumer brands, cultivation operations and ancillary services.

Although Greater Cannabis Acquisition Company has not yet announced a definitive merger or acquisition target, its stated investment strategy encompasses a broad range of cannabis-related activities. These include licensed cultivation and processing facilities, branded product lines spanning flower, oils and edibles, and technology-driven solutions for regulatory compliance, distribution logistics and retail point-of-sale systems. The SPAC structure allows Greater Cannabis Acquisition Company to move quickly on mergers that can scale operations and capitalize on ongoing cannabis legalization trends in North America.

The company is overseen by a management team and board of directors with experience in capital markets, corporate transactions and brand development. While specific leadership biographies are not broadly publicized, Greater Cannabis Acquisition Company operates under the sponsorship of an investment partnership with a track record in structuring and executing special-purpose acquisition vehicles. As of today, the firm continues to review potential targets in the U.S. and Canada, aiming to complete its first business combination within the SPAC’s mandated timeline.

Key Stats

• Today's Range: $0.15 to $0.15
• 50-Day Range: $0.15 to $0.27
• 52-Week Range: $0.04 to $0.45
• Volume: 156 shs
• Average Volume: 7,445 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:GCAN
• CIK: 1695473
• Web: www.gcanrx.com
• Phone: (443) 738-4051
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A